| Jun 19 |
What Makes Corcept Therapeutics (CORT) a Good Investment Bet?
|
| Jun 14 |
Teva accuses Corcept of monopolizing the market for Korlym
|
| Jun 14 |
Corcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?
|
| Jun 13 |
Teva sues Corcept over mifepristone 'monopoly' for rare disorder
|
| Jun 11 |
Insider-Owned Growth Companies To Watch On US Exchanges In June 2024
|
| Jun 11 |
Corcept Therapeutics Stock Merits Accumulation
|
| Jun 6 |
Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report?
|
| Jun 6 |
Insider Sale: Chief Development Officer William Guyer Sells 10,000 Shares of Corcept ...
|
| Jun 3 |
Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)
|
| May 31 |
Corcept (CORT) Up 24.5% Since Last Earnings Report: Can It Continue?
|
